看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
3 B. P* U4 c V2 I! l0 r7 Q0 i1 u' O' @6 Q6 D g
: T+ @+ ]+ ]. i
Currently available feasibility data for possible combination strategies.
7 {7 b0 ?5 \( `! u; x! u5 s1 _————————————————————————————————
9 y; n. h' |% ?Combination Feasibility according to preliminary data # J7 s6 ~0 J: G3 j8 h% P5 X3 `
——————————————————————————————————
2 E: V8 P% x0 E% d+ G7 [2 A& t; mBevacizumab + sorafenib Yes, reduced dose
' s' x) Z4 \* T. UBevacizumab + sunitinib† No " o3 T3 _+ P: G3 [4 u
Bevacizumab + temsirolimus Yes ' L1 C3 v8 h" H6 i
Bevacizumab + everolimus Yes * K; Q" f4 c7 q- ~ D" H" G% ^
Sorafenib + sunitinib ? " A8 W8 k0 U0 a0 ^9 I3 @1 c0 b
Sorafenib + temsirolimus Yes, reduced dose ( B2 g6 }" a! E+ H- B6 G7 S
Sorafenib + everolimus Yes, reduced dose
3 E3 V! A2 T' |* R5 LSunitinib + temsirolimus† No / x; {/ y9 i! M. L; Y' ?
Sunitinib + everolimus ?
3 |, J5 Q, a0 {: k9 s- vTemsirolimus + everolimus ? ; Z' ]% W$ P( o/ U5 X
————————————————————
4 f* ~/ Z* l+ q" O6 g& i†Led to US FDA warning.3 E9 i5 e7 k' F1 x
?: As yet unattempted combination.
$ @; L7 x; ]3 l- h |